https://www.selleckchem.com/pr....oducts/pimicotinib.h
ver metastasis (15 mo for lung metastasis 8 mo for liver metastasis, 0.001). CRA patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases. Those patients with M1a (lung metastasis) have superior long-term outcomes after palliative primary tumor resection. CRA patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases. Those patients with M1a (lung metastasis) have superior long-term outcomes after
Like
Comment
Share
